Serum HER-2/neu and response to megace vs an aromatase inhibitor
ALI SM
Proc Am Soc Clin Oncol 20 23a -23a
4
2001
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas
Asa Dahle-Smith , Zosia Miedzybrodzka , Anna Sapino , Cristina Migliore
Clinical Cancer Research 27 ( 11) 3126 -3140
2021
Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics
Razelle Kurzrock , Sherri Z. Millis , Siraj M. Ali , Denis L. Jardim
Oncologist 26 ( 4)
2021
Structure-function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting.
Christine M. Lovly , Marc Ladanyi , Jens Meiler , Ryma Benayed
Nature Communications 12 ( 1) 1382 -1382
22
2021
Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer
Jessica J. Lin , Viola W. Zhu , Satoshi Yoda , Beow Y. Yeap
Journal of Clinical Oncology 36 ( 12) 1199 -1206
263
2018
Abstract B06: Distinct genomic profiles and targetable alterations revealed by FoundationOne® Heme in hematolymphoid malignancies in adolescents and young adults.
Kai Wang , Deborah Morosini , Roman Yelensky , Doron Lipson
Clinical Cancer Research 21
2015
Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy
Siraj M. Ali , Ming Yao , Jicheng Yao , Jing Wang
Cancer 123 ( 18) 3628 -3637
24
2017
Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
Siraj M. Ali , Jeffrey S. Ross , Kai Wang
Cancer 124 ( 2) 435 -436
1
2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Jeffrey S. Ross , Marwan Fakih , Siraj M. Ali , Julia A. Elvin
Cancer 124 ( 7) 1358 -1373
129
2018
Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities
Sherri Z. Millis , Denis L. Jardim , Lee Albacker , Jeffrey S. Ross
Cancer 125 ( 7) 1185 -1199
36
2019
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
Rami N. Al-Rohil , Ashley J. Tarasen , J. Andrew Carlson , Kai Wang
Cancer 122 ( 2) 249 -257
40
2016
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.
Jeffrey S. Ross , Kai Wang , Depinder Khaira , Siraj M. Ali
Cancer 122 ( 5) 702 -711
55
2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Jeffrey S. Ross , Laurie M. Gay , Kai Wang , Siraj M. Ali
Cancer 122 ( 17) 2654 -2662
69
2016
Squamous Transformation of Prostate Adenocarcinoma: A Report of Two Cases With Genomic Profiling.
Nazli Dizman , Meghan Salgia , Siraj M. Ali , Huiqing Wu
Clinical Genitourinary Cancer 18 ( 3)
3
2020
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study.
Marco Bandini , Filippo Pederzoli , Russell Madison , Alberto Briganti
Clinical Genitourinary Cancer 18 ( 5)
5
2020
Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature
Lindsay Wilde , Siraj M. Ali , Charalambos C. Solomides , Jeffrey S. Ross
Clinical Genitourinary Cancer 15 ( 3) e521 -e524
9
2017
A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib.
Jon H. Chung , Siraj M. Ali , Jenni Davis , Karl Robstad
Case Reports in Oncology 7 ( 3) 628 -632
10
2014
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Douglas B. Johnson , Garrett M. Frampton , Matthew J. Rioth , Erik Yusko
Cancer immunology research 4 ( 11) 959 -967
259
2016
Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinoma.
Christine H. Chung , Alexis Germain , Rathan M. Subramaniam , Andreas M. Heilmann
Head and Neck-journal for The Sciences and Specialties of The Head and Neck 39 ( 1)
9
2017
Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
Lauren M. Thorpe , Alexa B. Schrock , Rachel L. Erlich , Vincent A. Miller
Head and Neck-journal for The Sciences and Specialties of The Head and Neck 39 ( 3)
23
2017
Alexa Schrock Garrett M Frampton Doron Lipson Sai-Hong Ignatius Ou Samuel Klempner, MD Zachary R Chalmers James X. Sun Roman Yelensky Sumanta Pal David M. Sabatini Shridar Ganesan Sugganth Daniel Dos Sarbassov Lee Albacker maurizio colecchia Do-Hyung Kim Alberto Briganti Christine M. Lovly, MD, PhD Andrea Gallina